International Psychopharmacology Algorithm Project information
Non-profit corporation
The International Psychopharmacology Algorithm Project (IPAP) is a non-profit corporation whose purpose is to "enable, enhance, and propagate" use of algorithms for the treatment of some Axis I psychiatric disorders.[1][2]
Kenneth O Jobson founded the Project. The Dean Foundation provides funding.
IPAP has organized and supported several international conferences on psychopharmacology algorithms. It has also supported the creation of several algorithms based on expert opinion. It is now in the process of creating "evidence-based algorithms," that is algorithms created by experts and annotated with the evidence that leads to these algorithms. A schizophrenia algorithm has been created and one on Post Traumatic Stress Disorder (PTSD) was released in July 2005. A general anxiety disorder (GAD) algorithm was released in 2006. Periodic updates of the algorithms are released as the basis of evidence changes. In addition, the algorithms are being translated into various non-English languages (Chinese, Japanese, Spanish, and Thai) as the availability of translators permits.[citation needed]
^Trivedi MH, DeBattista C, Fawcett J, Nelson C, Osser DN, Stein D, Jobson K (1998). "Developing treatment algorithms for unipolar depression in Cyberspace: International Psychopharmacology Algorithm Project (IPAP)". Psychopharmacology Bulletin. 34 (3): 355–359. PMID 9803769.
The InternationalPsychopharmacologyAlgorithmProject (IPAP) is a non-profit corporation whose purpose is to "enable, enhance, and propagate" use of algorithms...
F, Metzger E, Cloutier A, Osser DN (January 2021). "The PsychopharmacologyAlgorithmProject at the Harvard South Shore Program: An update on management...
PMID 28219485. Osser DN, Roudsari MJ, Manschreck T (2013). "The psychopharmacologyalgorithmproject at the Harvard South Shore Program: an update on schizophrenia"...
substantial and sustained personal meaning and spiritual significance". Psychopharmacology. 187 (3): 268–283. doi:10.1007/s00213-006-0457-5. PMID 16826400. S2CID 7845214...
S2CID 32085212. Osser DN, Roudsari MJ, Manschreck T (2013). "The psychopharmacologyalgorithmproject at the Harvard South Shore Program: an update on schizophrenia"...
emotional disturbance. The commission, using the Texas Medication AlgorithmProject (TMAP) as a blueprint, subsequently recommended screening of American...
of treatments for anxiety disorders: a meta-analysis". International Clinical Psychopharmacology. 30 (4): 183–192. doi:10.1097/YIC.0000000000000078. PMID 25932596...
substantial and sustained personal meaning and spiritual significance". Psychopharmacology. 187 (3): 268–283. doi:10.1007/s00213-006-0457-5. PMID 16826400. S2CID 7845214...
Journal International Journal of Drug Policy Journal of Drug Issues Journal of European Neuropsychopharmacology Journal of Psychopharmacology Therapeutic...
N.J.: John Wiley & Sons. ISBN 978-0470541494. "Psychopharmacology | Psychology Today International". psychologytoday.com. Archived from the original...
that affect brain functions, the chemicals that are the basis for psychopharmacology. Berger's early experiments recorded the effects of drugs on EEG....
as neuroscience, behavioural genetics, evolutionary biology, and psychopharmacology. The result is a growing practice of eclecticism, with psychologists...
of the Herb Salvia Divinorum: A Case Report". Journal of Clinical Psychopharmacology. 21 (6): 634–635. doi:10.1097/00004714-200112000-00025. PMID 11763023...
"The Effects of Sertraline on Psychopathic Traits". International Clinical Psychopharmacology. 26 (6): 329–337. doi:10.1097/YIC.0b013e32834b80df. ISSN 0268-1315...
Influential Scientific Minds”. The 2014 American Society for Clinical Psychopharmacology (ASCP): Donald L Klein Lifetime Achievement Award The 2014 Thomson...
exclusion criteria: is it 'cherry pickin'?". The Brown University Psychopharmacology Update. 13 (5). Wiley Periodicals: 1–3. May 2002. ISSN 1068-5308....
Global Information